384 related articles for article (PubMed ID: 17519645)
1. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
[TBL] [Abstract][Full Text] [Related]
2. Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study.
Biancosino B; Barbui C; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2005 Nov; 20(6):305-9. PubMed ID: 16192838
[TBL] [Abstract][Full Text] [Related]
3. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
4. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
Santone G; Bellantuono C; Rucci P; Picardi A; Preti A; de Girolamo G
Pharmacoepidemiol Drug Saf; 2011 May; 20(5):441-9. PubMed ID: 21523847
[TBL] [Abstract][Full Text] [Related]
5. Use of atypical antipsychotic medications in adolescent psychiatric inpatients: a comparison with inpatients who did not receive antipsychotic medications during their stay.
Pogge DL; Young K; Insalaco B; Harvey PD
Int J Clin Pract; 2007 Jun; 61(6):896-902. PubMed ID: 17504351
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
[TBL] [Abstract][Full Text] [Related]
7. Patterns of clinical use of antipsychotics in hospitalized psychiatric patients.
Mauri MC; Regispani F; Beraldo S; Volonteri LS; Ferrari VM; Fiorentini A; Invernizzi G
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):957-63. PubMed ID: 16051409
[TBL] [Abstract][Full Text] [Related]
8. Prescribing for inpatients with schizophrenia: an international multi-center comparative study.
Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P
Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
10. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Pharmacopsychiatry; 2007 Mar; 40(2):47-52. PubMed ID: 17447172
[TBL] [Abstract][Full Text] [Related]
11. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
[TBL] [Abstract][Full Text] [Related]
13. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.
Dickey B; Normand SL; Eisen S; Hermann R; Cleary P; Cortés D; Ware N
Med Care; 2006 Sep; 44(9):827-34. PubMed ID: 16932134
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic medication utilization trends among Texas veterans: 1997-2002.
Yang M; Barner JC; Lawson KA; Rascati KL; Wilson JP; Crismon ML; Worchel J; Mascarenas CA
Ann Pharmacother; 2008 Sep; 42(9):1229-38. PubMed ID: 18682544
[TBL] [Abstract][Full Text] [Related]
15. Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004.
Centorrino F; Ventriglio A; Vincenti A; Talamo A; Baldessarini RJ
Hum Psychopharmacol; 2010 Mar; 25(2):179-86. PubMed ID: 20196186
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore.
Sim K; Su A; Chan YH; Shinfuku N; Kua EH; Tan CH
Psychiatry Clin Neurosci; 2004 Jun; 58(3):324-9. PubMed ID: 15149301
[TBL] [Abstract][Full Text] [Related]
17. The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients.
Andersen SE; Johansson M; Manniche C
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):75-81. PubMed ID: 18346047
[TBL] [Abstract][Full Text] [Related]
18. Use of combinations of antipsychotics: McLean Hospital inpatients, 2002.
Centorrino F; Fogarty KV; Sani G; Salvatore P; Cincotta SL; Hennen J; Guzzetta F; Talamo A; Saadeh MG; Baldessarini RJ
Hum Psychopharmacol; 2005 Oct; 20(7):485-92. PubMed ID: 16116665
[TBL] [Abstract][Full Text] [Related]
19. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients.
Procyshyn RM; Honer WG; Wu TK; Ko RW; McIsaac SA; Young AH; Johnson JL; Barr AM
J Clin Psychiatry; 2010 May; 71(5):566-73. PubMed ID: 20361903
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic polypharmacy among patients admitted to a geriatric psychiatry unit.
Dolder CR; McKinsey J
J Psychiatr Pract; 2011 Sep; 17(5):368-74. PubMed ID: 21926533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
